Exploring the Link between Germline and Somatic Genetic Alterations in Breast Carcinogenesis

• Núria Bonifaci,

  Affiliation Biomarkers and Susceptibility Unit, Spanish Biomedical Research Centre Network for Epidemiology and Public Health, Catalan Institute of Oncology, L'Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet, Barcelona, Spain

  ⨯
• Bohdan Górski,

  Affiliation Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland

  ⨯
• Bartlomiej Masojć,

  Affiliation Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland

  ⨯
• Dominika Wokołorczyk,

  Affiliation Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland

  ⨯
• Anna Jakubowska,

  Affiliation Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland

  ⨯
• Tadeusz Dębniak,

  Affiliation Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland

  ⨯
• Antoni Berenguer,

  Affiliation Biomarkers and Susceptibility Unit, Spanish Biomedical Research Centre Network for Epidemiology and Public Health, Catalan Institute of Oncology, L'Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet, Barcelona, Spain

  ⨯
• Jordi Serra Musach,

  Affiliation Biomarkers and Susceptibility Unit, Spanish Biomedical Research Centre Network for Epidemiology and Public Health, Catalan Institute of Oncology, L'Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet, Barcelona, Spain

  ⨯
• Joan Brunet,

  Affiliation Hereditary Cancer Programme, Catalan Institute of Oncology, IdIBGi, Girona, Spain

  ⨯
• Joaquín Dopazo,

  Affiliation Department of Bioinformatics and Genomics, Centro de Investigación Príncipe Felipe, Functional Genomics Node and Spanish Biomedical Research Centre Network for Rare Diseases, Valencia, Spain

  ⨯
• Steven A. Narod,

  Affiliation Womens College Research Institute, University of Toronto and Women's College Hospital, Toronto, Ontario, Canada

  ⨯
• Jan Lubiński,

  Affiliation Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland

  ⨯
• Conxi Lázaro,

  Affiliation Hereditary Cancer Programme, Catalan Institute of Oncology, IDIBELL, L'Hospitalet, Barcelona, Spain

  ⨯
• Cezary Cybulski ,

  * E-mail: cezarycy@sci.pam.szczecin.pl (CC); mapujana@iconcologia.net (MAP)

  Affiliation Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland

  ⨯
• Miguel Angel Pujana

  * E-mail: cezarycy@sci.pam.szczecin.pl (CC); mapujana@iconcologia.net (MAP)

  Affiliations Biomarkers and Susceptibility Unit, Spanish Biomedical Research Centre Network for Epidemiology and Public Health, Catalan Institute of Oncology, L'Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet, Barcelona, Spain, Translational Research Laboratory, Catalan Institute of Oncology, IDIBELL, L'Hospitalet, Barcelona, Spain

  ⨯